{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:33:27Z","timestamp":1787016807129,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1989,5,1]],"date-time":"1989-05-01T00:00:00Z","timestamp":609984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1989,5,1]],"date-time":"1989-05-01T00:00:00Z","timestamp":609984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1989,5]]},"DOI":"10.1136\/ard.48.5.358","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T19:49:46Z","timestamp":1217274586000},"page":"358-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the \u2018primary\u2019 antiphospholipid syndrome."],"prefix":"10.1016","volume":"48","author":[{"given":"R.A","family":"Asherson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Merry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F","family":"Acheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.N","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.R","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref_1","first-page":"800","article-title":"Ocular findings in systemic lupus erythematosus. Br 1 Ophthalmol","volume":"56","author":"H, Gold D.; A, Morris D.; P, Hertrind","year":"1972","unstructured":"Gold D H, Morris D A, Hertrind P. Ocular findings in systemic lupus erythematosus. Br 1 Ophthalmol 1972; 56: 800-4."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archopht.1986.01050160114025","article-title":"Severe retinal vaso-occlusive disease in systemic lupus erythematosus","volume":"104","author":"A, Jabs D.; L, Fine S.; C, Hochberg M.; A, Newman S.; G, Heiner G.; B, Stevens M.","year":"1986","unstructured":"Jabs D A, Fine S L, Hochberg M C, Newman S A, Heiner G G, Stevens M B. Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol 1986; 104: 558-63.","journal-title":"Arch Ophthalmol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.1986.01050160120026","article-title":"Optic neuropathy in systemic lupus erythematosus","volume":"104","author":"A, Jabs D.; R, Miller N.; A, Newman S.","year":"1986","unstructured":"Jabs D A, Miller N R, Newman S A, et al. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 1986; 104: 564-8.","journal-title":"Arch Ophthalmol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/ard.41.5.473","article-title":"SLE retinopathy evaluation by fluorescein angiography","volume":"41","author":"G, Lanham J.; T, Barrie; M, Kohner E.; V, Hughes G.R.","year":"1982","unstructured":"Lanham J G, Barrie T, Kohner E M, Hughes G R V. SLE retinopathy evaluation by fluorescein angiography. Ann Rheum Dis 1982; 41: 473-8.","journal-title":"Ann Rheum Dis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bjo.39.1.1","article-title":"Ocular changes in systemic lupus erythematosus","volume":"39","author":"Clifton, F.; H, Green C.","year":"1955","unstructured":"Clifton F, Green C H. Ocular changes in systemic lupus erythematosus. Br J Ophthalmol 1955; 39: 1-10.","journal-title":"Br J Ophthalmol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/art.1780150109","article-title":"Retinopathy in systemic lupus erythematosus","volume":"15","author":"Bishko, F.","year":"1972","unstructured":"Bishko F. Retinopathy in systemic lupus erythematosus. Arthritis Rheum 1972; 15: 57-63.","journal-title":"Arthritis Rheum"},{"key":"ref_7","first-page":"444","article-title":"Cerebral and retinal vascular changes in systemic lupus erythematosus","volume":"0","author":"M, Graham E.; Garner, A.; W, Russell R.","year":"1985","unstructured":"Graham E M, Spalton D J, Barnard R 0, Garner A, Russell R W. Cerebral and retinal vascular changes in systemic lupus erythematosus. Ophthalmology 1985; 92: 444-8.","journal-title":"Ophthalmology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.46.1.1","article-title":"Anticardiolipin antibodies: isotype distribution and phospholipid specificity","volume":"46","author":"E, Gharavi A.; N, Harris E.; A, Asherson R.; V, Hughes G.R.","year":"1987","unstructured":"Gharavi A E, Harris E N, Asherson R A, Hughes G R V. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.","journal-title":"Ann Rheum Dis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/pgmj.62.734.1081","article-title":"Anticardiolipin antibodies-clinical associations","volume":"62","author":"A, Asherson R.; N, Harris E.","year":"1986","unstructured":"Asherson R A, Harris E N. Anticardiolipin antibodies-clinical associations. Postgrad Med J 1986; 62: 1081-7.","journal-title":"Postgrad Med J"},{"key":"ref_10","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"V, Hughes G.R.; N, Harris E.; E, Gharavi A.","year":"1986","unstructured":"Hughes G R V, Harris E N, Gharavi A E. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-9.","journal-title":"J Rheumatol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.me.39.020188.001401","article-title":"Antiphospholipid antibodies-autoantibodies with a difference","volume":"39","author":"N, Harris E.; A, Asherson R.; V, Hughes G.R.","year":"1988","unstructured":"Harris E N, Asherson R A, Hughes G R V. Antiphospholipid antibodies-autoantibodies with a difference. Annual Review of Medicine 1988; 39: 261-71.","journal-title":"Annual Review of Medicine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.47.2.110","article-title":"Anticardiolipin antibodies, livedo recticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus","volume":"47","author":"J, McHugh N.; H, Maymo; P, Skinner R.; I, James; J, Maddison P.","year":"1988","unstructured":"McHugh N J, Maymo H, Skinner R P, James I, Maddison P J. Anticardiolipin antibodies, livedo recticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus. Ann Rheum Dis 1988; 47: 110-5.","journal-title":"Ann Rheum Dis"},{"key":"ref_13","first-page":"69","article-title":"Black","volume":"30","author":"A, Asherson R.; S, Mayou","year":"1987","unstructured":"Asherson R A, Mayou S, Black M, Harris E N, Hughes E RV. Livedo reticularis, connective tissue disease, anticardiolipin antibodies and CNS complications [Abstract]. Arthritis Rheum 1987; 30: S69.","journal-title":"Arthritis Rheum; RV. Livedo reticularis, connective tissue disease, anticardiolipin antibodies and CNS complications"},{"key":"ref_14","first-page":"595","article-title":"Lupus anticoagulant associated with aortic and mitral valve insufficiency","volume":"29","author":"K, Chartash E.; A, Paget S.; D, Lockshin M.","year":"1986","unstructured":"Chartash E K, Paget S A, Lockshin M D. Lupus anticoagulant associated with aortic and mitral valve insufficiency. Arthritis Rheum 1986; 29: 595.","journal-title":"Arthritis Rheum"},{"key":"ref_15","first-page":"795","article-title":"IgG and IgM anticardiolipin antibodies in patients with lupus and anticardiolipin antibody associated clinical syndromes","volume":"15","author":"E, Cronin M.; H, Biswas R.; der Straeton C, Van; A, Fleisher T.; H, Klippel J.","year":"1988","unstructured":"Cronin M E, Biswas R H, Van der Straeton C, Fleisher T A, Klippel J H. IgG and IgM anticardiolipin antibodies in patients with lupus and anticardiolipin antibody associated clinical syndromes. J Rheumatol 1988; 15: 795-8.","journal-title":"J Rheumatol"},{"issue":"1","key":"ref_16","first-page":"31","article-title":"Valvular lesions in SLE: a possible relationship with antiphospholipid antibodies and cerebrovascular disease","volume":"27","author":"Baguley, E.; Byrne, C.; A, Asherson R.; Coltart, J.; V, Hughes G.R.","year":"1988","unstructured":"Baguley E, Byrne C, Asherson R A, Coltart J, Hughes G R V. Valvular lesions in SLE: a possible relationship with antiphospholipid antibodies and cerebrovascular disease. Br J Rheumatol 1988; 27 (suppl 1): 31.","journal-title":"Br J Rheumatol"},{"key":"ref_17","first-page":"597","article-title":"Association of lupus anticoagulant with severe valvular heart disease in SLE","volume":"15","author":"M, Ford P.; E, Ford S.; P, Lillicrap D.","year":"1988","unstructured":"Ford P M, Ford S E, Lillicrap D P. Association of lupus anticoagulant with severe valvular heart disease in SLE. J Rheumatol 1988; 15: 597-600.","journal-title":"J Rheumatol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/ard.47.11.947","article-title":"Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks","volume":"47","author":"A, Asherson R.; G, Gibson D.; W, Evans D.; E, Baguley; V, Hughes G.R.","year":"1988","unstructured":"Asherson R A, Gibson D G, Evans D W, Baguley E, Hughes G R V. Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks. Ann Rheum Dis 1988; 47: 947-53.","journal-title":"Ann Rheum Dis"},{"key":"ref_19","first-page":"539","article-title":"Cerebral and valve lesions in SLE in association with antiphospholipid antibodies","volume":"15","author":"A, Asherson R.; F, Lubbe W.","year":"1988","unstructured":"Asherson R A, Lubbe W F. Cerebral and valve lesions in SLE in association with antiphospholipid antibodies. J Rheumatol 1988; 15: 539-43.","journal-title":"J Rheumatol"},{"key":"ref_20","article-title":"A 'primary' antiphospholipid syndrome","author":"A, Asherson R.","unstructured":"Asherson R A. A 'primary' antiphospholipid syndrome. J Rheumatol (in press).","journal-title":"J Rheumatol"},{"issue":"2","key":"ref_21","first-page":"19","article-title":"Clinical and serological features of the 'antiphospholipid syndrome'","volume":"26","author":"N, Harris E.; E, Baguley; A, Asherson R.; V, Hughes G.R.","year":"1987","unstructured":"Harris E N, Baguley E, Asherson R A, Hughes G R V. Clinical and serological features of the 'antiphospholipid syndrome'. Br J Rheumatol 1987; 26 (suppl 2): 19.","journal-title":"Br J Rheumatol"},{"key":"ref_22","first-page":"94","article-title":"Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Br","volume":"2","author":"G, Mackworth-Young C.; J, David; S, Loizou; M, Walport","year":"1987","unstructured":"Mackworth-Young C G, David J, Loizou S, Walport M. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Br J Rheumatol 1987; 26 (suppl 2): 94.","journal-title":"J Rheumatol"},{"key":"ref_23","first-page":"1271","article-title":"revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"M, Tan E.; S, Cohen A.; A, Fries J.","year":"1982","unstructured":"Tan E M, Cohen A S, Fries J A, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.","journal-title":"The"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/bmj.296.6617.294","article-title":"Management of retinal vein occlusion","volume":"296","author":"Merry, P.; F, Acheson J.; A, Asherson R.; V, Hughes G.R.","year":"1988","unstructured":"Merry P, Acheson J F, Asherson R A, Hughes G R V. Management of retinal vein occlusion. Br Med J 1988; 296: 294.","journal-title":"Br Med J"},{"key":"ref_25","first-page":"846","article-title":"Occlusive retinal vascular disease in systemic lupus erythematosus","volume":"11","author":"Hall, S.; Buettner, H.; S, Luthra H.","year":"1984","unstructured":"Hall S, Buettner H, Luthra H S. Occlusive retinal vascular disease in systemic lupus erythematosus. J Rheumatol 1984; 11: 846-9.","journal-title":"J Rheumatol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/art.1780210716","article-title":"Central retinal vein occlusion complicating systemic lupus erythematosus","volume":"21","author":"Silverman, H.; J, Lubeck M.; G, Briney W.","year":"1978","unstructured":"Silverman H, Lubeck M J, Briney W G. Central retinal vein occlusion complicating systemic lupus erythematosus. Arthritis Rheum 1978; 21: 839-43.","journal-title":"Arthritis Rheum"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajh.2830190308","article-title":"anticoagulant: an analysis of the clinical and laboratory features of 219 cases","volume":"19","author":"A, Gastineau D.","year":"1985","unstructured":"Gastineau D A, Kazmier F J, Nichols W L, Bowie E J M. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol 1985; 19: 265-75.","journal-title":"Am J Hematol"},{"key":"ref_28","first-page":"254","article-title":"Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature","volume":"15","author":"Lechner, K.; Pabinger-Fasching, I.","year":"1983","unstructured":"Lechner K, Pabinger-Fasching I. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1983; 15: 254-62.","journal-title":"Haemostasis"},{"key":"ref_29","first-page":"1","article-title":"Thrombosis and immune disorders","volume":"15","author":"Vermylen, J.; Blockmans, D.; Spitz, B.; Deckmyn, H.","year":"1986","unstructured":"Vermylen J, Blockmans D, Spitz B, Deckmyn H. Thrombosis and immune disorders. Clin Haematol 1986; 15: 1-17.","journal-title":"Clin Haematol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9394(86)90206-0","article-title":"Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies","volume":"102","author":"Jonas, J.; Kolble, K.; E, Volker H.; Kalden, R.","year":"1986","unstructured":"Jonas J, Kolble K, Volker H E, Kalden R. Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies. Am J Ophthalmol 1986; 102: 37-40.","journal-title":"Am J Ophthalmol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2133.1965.tb14628.x","article-title":"Cerebrovascular lesions and livedo reticularis","volume":"77","author":"B, Sneddon I.","year":"1965","unstructured":"Sneddon I B. Cerebrovascular lesions and livedo reticularis. Br J Dermatol 1965; 77: 180.","journal-title":"Br J Dermatol"},{"key":"ref_32","article-title":"Cerebrovascular disease and antiphospholipid antibodies","author":"A, Asherson R.; M, Khamshta; E, Baguley","unstructured":"Asherson R A, Khamshta M, Baguley E, et al. Cerebrovascular disease and antiphospholipid antibodies. Am J Med (in press).","journal-title":"Am J Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724109855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724109855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.48.5.358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:29:29Z","timestamp":1737505769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724109855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1989,5]]}},"alternative-id":["S0003496724109855"],"URL":"https:\/\/doi.org\/10.1136\/ard.48.5.358","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1989,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the \u2018primary\u2019 antiphospholipid syndrome.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.48.5.358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1136\/ard.49.3.203","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1989 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}